• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Daily diet of fresh fruit linked to lower diabetes risk
Conclusion The study findings – that eating fresh fruit every day does not raise the risk of diabetes, and may reduce it – are reassuring and in line with dietary advice in the UK. It's also helpful to see evidence that people who already have diabetes are likely to benefit from fresh fruit as well, because there has not been much research into fruit-eating for people with diabetes. However, it's a step too far to say that fresh fruit prevents diabetes or diabetes complications. Fresh fruit is just one part of a healthy diet, and diet is just one of the things that may affect someone's risk of getting diabetes. This ty...
Source: NHS News Feed - April 12, 2017 Category: Consumer Health News Tags: Diabetes Food/diet Source Type: news

Fit middle-aged men have lower cancer risk
Conclusion This study shows that cardiovascular fitness is likely to reduce men's chances of developing lung and colorectal cancer, and appears to boost survival from cancer or cardiovascular disease in those diagnosed after the age of 65. This was based on comparing the top 40% of fittest men with the 20% least fit. The study focused on fitness and took account of major risk factors for cancer, such as smoking and blood pressure. However, it left out one important risk factor: diet. What people eat and drink is known to affect cancer risk. The fittest group may also have been the healthiest in terms of eating well and ...
Source: NHS News Feed - March 27, 2015 Category: Consumer Health News Tags: Cancer Lifestyle/exercise Source Type: news

Media dementia scare over hay fever and sleep drugs
Conclusion This large US prospective cohort study suggests a link between those taking high levels of anticholinergic medicines for more than three years and developing dementia in adults over 65. The main statistically significant finding was in a group taking the equivalent of any of the following medications daily for more than three years: xybutynin chloride, 5mg chlorpheniramine maleate, 4mg olanzapine, 2.5mg meclizine hydrochloride, 25mg doxepin hydrochloride, 10mg These are not unrealistic doses of medicine, so the results may be applicable to a significant proportion of older adults. The main lim...
Source: NHS News Feed - January 27, 2015 Category: Consumer Health News Tags: Medication Neurology Source Type: news

Prescription sleeping pills linked to Alzheimer's risk
Conclusion This case control study has suggested that long-term use of benzodiazepines (over six months) may be linked with an increased risk of Alzheimer’s disease in older people. These findings are reported to be similar to other previous studies, but add weight to these by showing that risk increases with increasing length of exposure to the drugs, and with those benzodiazepines that remain in the body for longer. The strengths of this study include that it could establish when people started taking benzodiazepines and when they had their diagnosis using medical insurance records, rather than having to ask people to ...
Source: NHS News Feed - September 10, 2014 Category: Consumer Health News Tags: Neurology Mental health Source Type: news

Could statins also protect against dementia?
Conclusion This study using a large, older age, Asian population finds an association between statin use and reduced risk of developing dementia over an average five years of follow-up. The main limitation of this study is that it can demonstrate an association, but it cannot definitely prove cause and effect. The study has adjusted for a number of measured confounders, but this may not fully account for these or other factors (such as lifestyle habits) that may be involved in the relationship.  Also, while the research has used what can be expected to be a fairly reliable research database, there is also the possibility...
Source: NHS News Feed - April 14, 2014 Category: Consumer Health News Tags: Medication Neurology Source Type: news

Diabetes drugs may be linked to pancreatic cancer
Conclusion This article presents important concerns that glucagon-like peptide-1 (GLP-1) agonists and dipeptidylpeptidase-4 (DPP-4) inhibitors could potentially increase the risk of inflammation and cancerous changes in the pancreas. The agencies that regulate medicines in Europe and the USA are aware of these issues, and told the BMJ that their analyses show increased reporting of pancreatic cancer among people taking these types of drugs. However, the agencies note that it has not been established whether these drugs directly cause the adverse effects seen in the pancreas. Both agencies are reviewing emerging eviden...
Source: NHS News Feed - June 10, 2013 Category: Consumer Health News Tags: Medication Diabetes QA articles Source Type: news